| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |